x-octo home Business judgment on AI products
中文

Real-revenue cases

Dosefi

Real demand

Dosefi is a lean health app that does one job: logging medication doses and sending reminders. It runs entirely on subscriptions, with monthly and annual plans both live, and TrustMRR verifies $107 per month in Stripe-verified recurring revenue.

Stripe-verified
Monthly revenue
$107 / mo
Primary source
View original

01

Real-demand verdict

Real-demand verdict

Real demand

Taking medication on schedule is a daily, repeating job, and the app replaces tracking it from memory, alarms, or paper. Stripe-verified recurring revenue confirms people keep paying for that single job.

How it makes money

All revenue is subscription-based: users pay monthly or annually, and the source says both plans are live and converting. Stripe-verified MRR is $107.

What old behavior it replaces

Managing daily medication from memory, phone alarms, or paper logs.

02

Where the first customers came from

Not mentioned in the source material.

03

Tactics you can copy

  1. 01Keep the product to a single job — dose logging and reminders only; the source stresses it is a single-purpose tool.
  2. 02Launch with both monthly and annual subscription plans from day one; the source says both are converting.
  3. 03Route all revenue through Stripe and verify it publicly on a site like TrustMRR, so the MRR number itself becomes proof of real income.
Moving it to an AI business

Dosefi isn't an AI product, but the validation loop transfers directly: build an AI tool that does exactly one task, ship monthly and annual plans on day one, and treat Stripe-verified MRR — even $107 — as the demand signal instead of signups or traffic.

04

Evidence and limits

Self-reported numbers are unaudited — treat them as leads, not facts
Stripe-verified

Revenue basis · Stripe-verified (TrustMRR)

What evidence is missing

No subscriber count or exact plan prices are given, so the $107 MRR can't be broken down into price and volume.
Acquisition channels, first users, and growth trend are all missing, so there's no way to tell whether revenue is still growing.
The material doesn't say whether the product uses AI, and there's no retention or churn data, so subscription durability is unknown.